ENETS consensus guidelines for the standards of care in neuroendocrine tumors: Follow-up and documentation

Neuroendocrinology

Volumn 90, Issue 2, 2009, Pages 227-233

  Arnold, Rudolf ^a,k   Chen, Yuan Jia ^b   Costa, Frederico ^c   Falconi, Massimo ^d   Gross, David ^e   Grossman, Ashley B ^f   Hyrdel, Rudolf ^g   Kos Kudła, Beata ^h   Salazar, Ramon ⁱ   Plöckinger, Ursula ^j   Åkerström, Göran ^l   Annibale, Bruno ^m   Bajetta, Emilio ⁿ   Barkmanova, Jaroslava ^o   Couvelard, Anne ^p   Davar, Joseph ^q   De Herder, Wouter ^r   Delle Fave, Gianfranco ^s   Eriksson, Barbro ^l   Ferone, Diego ^t   Gustafsson, Björn ^u   Ivan, Diana ^a   Kaltsas, Gregory ^v   Kianmanesh, Reza ^w   Klöppel, Günter ^x   Knigge, Ulrich Peter ^y   Komminoth, Paul ^z   Kwekkeboom, Dik ^r   Lebtahi, Rachida ^aa   Lewington, Val ^ab   McNicol, Anne Marie ^ac   Mitry, Emmanuel ^ad   Nilsson, Ola ^ae   Öberg, Kjell ^l   O'Connor, Juan ^af   O'Toole, Dermot ^ag   Pape, Ulrich Frank ^j   Papotti, Mauro ^ah   Pavel, Marianne ^j   Perren, Aurel ^ai   Platania, Marco ⁿ   Rindi, Guido ^aj   Ruszniewski, Philippe ^p   Scarpa, Aldo ^d   Scheidhauer, Klemens ^ai   Scoazec, Jean Yves ^ak   Sundin, Anders ^l   Szpak, Waldemar ^al   Taal, Babs ^am   Vitek, Pavel ^o   Vullierme, Marie Pierre ^p   Wiedenmann, Bertram ^j   more..

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c HOSPITAL SÍRIO LIBANÊS   (Brazil)

^d UNIVERSITY OF VERONA   (Italy)

^e HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^f ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^g Martinska Fakultna Nemocnica   (Slovakia)

^h MEDICAL UNIVERSITY OF SILESIA   (Poland)

ⁱ CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k University Hospital ^*  (Germany)

^l UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^m SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁿ NATIONAL CANCER INSTITUTE   (Italy)

^o CHARLES UNIVERSITY   (Czech Republic)

^p BEAUJON HOSPITAL   (France)

^q ROYAL FREE HOSPITAL   (United Kingdom)

^r ERASMUS MEDICAL CENTER   (Netherlands)

^s SAPIENZA UNIVERSITY OF ROME   (Italy)

^t UNIVERSITY OF GENOA   (Italy)

^u TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^v G GENNIMATAS GENERAL HOSPITAL   (Greece)

^w HÔPITAL LOUIS MOURIER   (France)

^x TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^y Rigshospitalet   (Denmark)

^z TRIEMLI HOSPITAL   (Switzerland)

^aa BICHAT HOSPITAL   (France)

^ab INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^ac GLASGOW ROYAL INFIRMARY   (United Kingdom)

^ad HÔPITAL AMBROISE PARÉ   (France)

^ae SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^af INSTITUTO ALEXANDER FLEMING   (Argentina)

^ag ST JAMES S HOSPITAL   (Ireland)

^ah UNIVERSITY OF TURIN   (Italy)

^ai TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^aj UNIVERSITY OF PARMA   (Italy)

^ak EDOUARD HERRIOT HOSPITAL   (France)

^al Westville Hospital   (South Africa)

^am Netherlands Cancer Centre   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PENTETREOTIDE; TUMOR MARKER;

APPENDIX TUMOR; BENIGN TUMOR; CANCER DIAGNOSIS; CANCER GRADING; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; ECHOGRAPHY; ENDOSCOPIC SURGERY; FOLLOW UP; GENETIC SCREENING; HUMAN; HYPOPHYSIS; INSULINOMA; LIVER METASTASIS; MEDICAL DOCUMENTATION; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PARATHYROID GLAND; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

DOCUMENTATION; FOLLOW-UP STUDIES; HUMANS; MEDICAL HISTORY TAKING; MEDICAL RECORDS; NEOPLASM STAGING; NEUROENDOCRINE TUMORS;

EID: 69749100391     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000225952     Document Type: Conference Paper

References (11)

1. Solcia E, Klöppel G, Sobin LH; in collaboration with 9 pathologists from 4 countries: Histological Typing of Endocrine Tumours. International Histological Classification of Tumours, ed 2. World Health Organization. Berlin, Springer, 2000.
2. Capella, C, Heitz PU, Höfler H, Solcia E, Klöppel G: Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 1995;425:547-560.
3. Rindi G, Klöppel, G, Ahlman H, Caplin M, et al: TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006;449:396-401. (Pubitemid 44451313)
4. Rindi G, Klöppel G, Couvelard A, Komminoth P, et al: TNM staging of midgut and hindgut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2007;451:757-762. (Pubitemid 47497934)
5. Gabriel M, Decristoforo C, Kendler D, Dobrozemsky G, et al: 68 Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med 2007;48:508-518. (Pubitemid 47571404)
6. Buchmann I, Henze M, Engelbrecht S, Eisenhut M, et al: Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 2007;34:1617-1626. (Pubitemid 47476920)
7. Kayani I, Bomanji JB, Groves A, Conway G, et al: Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG. Cancer 2008; 112: 2447-2455.
8. Arnold R, Wilke A, Rinke A, Mayer C, et al: Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastro- enteropancreatic tumors. Clin Gastroenterol Hepatol 2008;6:820-829.
9. Öberg K, Janson ET, Eriksson B: Tumour markers in neuroendocrine tumours. Ital J Gastroenterol Hepatol 1999;31(suppl 2):160-162.
10. Janson ET, Holmberg L, Stridsberg M, et al: Carcinoid tumors: analysis of prognostic factors and survival in 301 patients. Ann Oncol 1997;8:685-690.
11. Stridsberg M, Erikkson B, Öberg K, et al: A comparison between three commercial kits for chromogranin A measurements. J Endocrinol 2003;177:337-341. (Pubitemid 36656407)